Clinical trial
Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With…
NCT00296348 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00296348 |
|---|---|
| Title | Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation |
| Official title | An Open, Randomised, Multicentre Clinical Study to Investigate the Safety and Efficacy of Steroid Withdrawal With Tacrolimus, Mycophenolate Mofetil and Daclizumab Against Tacrolimus, Mycophenolate Mofetil and Steroids in Children After Kidney Transplantation |
| Acronym | TWIST |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | tacrolimus, mycophenolate mofetil, daclizumab, steroids |
| Enrollment | 198 |
| Start date | Nov 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Feb 27, 2006 |
| Last update posted | Jun 26, 2015 |
| Countries | Belgium, Czechia, France, Germany, Hungary, Israel, Italy, Poland, Romania, South Africa, Sweden, Taiwan and 2 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: